|  Help  |  About  |  Contact Us

Publication : Knockdown of phospholipase C-β1 in the medial prefrontal cortex of male mice impairs working memory among multiple schizophrenia endophenotypes.

First Author  Kim SW Year  2015
Journal  J Psychiatry Neurosci Volume  40
Issue  2 Pages  78-88
PubMed ID  25268789 Mgi Jnum  J:258958
Mgi Id  MGI:6140938 Doi  10.1503/jpn.130285
Citation  Kim SW, et al. (2015) Knockdown of phospholipase C-beta1 in the medial prefrontal cortex of male mice impairs working memory among multiple schizophrenia endophenotypes. J Psychiatry Neurosci 40(2):78-88
abstractText  BACKGROUND: Decreased expression of phospholipase C-beta1 (PLC-beta1) has been observed in the brains of patients with schizophrenia, but, to our knowledge, no studies have shown a possible association between this altered PLC-beta1 expression and the pathogenesis of schizophrenia. Although PLC-beta1-null (PLC-beta1(-/-)) mice exhibit multiple endophenotypes of schizophrenia, it remains unclear how regional decreases in PLC-beta1 expression in the brain contribute to specific behavioural defects. METHODS: We selectively knocked down PLC-beta1 in the medial prefrontal cortex (mPFC) using a small hairpin RNA strategy in mice. RESULTS: Silencing PLC-beta1 in the mPFC resulted in working memory deficits, as assayed using the delayed non-match-to-sample T-maze task. Notably, however, other schizophrenia-related behaviours observed in PLC-beta1-/- mice, including phenotypes related to locomotor activity, sociability and sensorimotor gating, were normal in PLC-beta1 knockdown mice. LIMITATIONS: Phenotypes of PLC-beta1 knockdown mice, such as locomotion, anxiety and sensorimotor gating, have already been published in our previous studies. Further, the neural mechanisms underlying the working memory deficit in mice may be different from those in human schizophrenia. CONCLUSION: These results indicate that PLC-beta1 signalling in the mPFC is required for working memory. Importantly, these results support the notion that the decrease in PLC-beta1 expression in the brains of patients with schizophrenia is a pathogenically relevant molecular marker of the disorder.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression